Stage IV lung cancer survivor: Targeted therapy clinical trial is giving me another chance

Everyone is dealt a card or two in life that will pose their greatest challenges. For me, that card was being diagnosed with stage III lung cancer in September 2013. At the time, I was a healthy 42-year-old who had never so much as picked up a cigarette. Nobody in my family had ever smoked either. So, to say the diagnosis came as a shock is no understatement. Following my intuition saved my daughter’s life I found out I had cancer just after the birth of my daughter, Kate. I felt great until the day she was born, but because I was 41 when she was conceived, mine was considered a high-risk pregnancy. That meant I needed monthly ultrasounds. Things were going so well during my eighth month that my obstetrician said we could skip the last ultrasound. But something told me not to, and to this day, I am so grateful that I didn’t. Because it was during that scan that we discovered my daughter had stopped growing. She’d gone from 90% in gestational size to 10% in just three weeks. Something was very, very wrong. I was rushed to a local hospital, where tests revealed that I had HELLP syndrome, a potentially life-threatening condition that occurs in less than 1% of pregnancies. It’s hard to diagnose, and can be fatal to both expectant mothers and their unborn children. The doctors also discovered that my placenta had shut down. My daughter was literally starving. I needed an emergency C-section immediately. Divine intervention — and an unexpected scan — saved my life My daughter, Kate, was born without complications...